ATE299144T1 - Verfahren zur herstellung einer pharmazeutisch aktiven verbindung (granisetron) - Google Patents

Verfahren zur herstellung einer pharmazeutisch aktiven verbindung (granisetron)

Info

Publication number
ATE299144T1
ATE299144T1 AT03706845T AT03706845T ATE299144T1 AT E299144 T1 ATE299144 T1 AT E299144T1 AT 03706845 T AT03706845 T AT 03706845T AT 03706845 T AT03706845 T AT 03706845T AT E299144 T1 ATE299144 T1 AT E299144T1
Authority
AT
Austria
Prior art keywords
granisetron
compound
formula
producing
active compound
Prior art date
Application number
AT03706845T
Other languages
English (en)
Inventor
Barjoan Pere Dalmases
Torres Salvador Puig
Original Assignee
Vita Cientifica S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Cientifica S L filed Critical Vita Cientifica S L
Application granted granted Critical
Publication of ATE299144T1 publication Critical patent/ATE299144T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT03706845T 2002-03-26 2003-03-21 Verfahren zur herstellung einer pharmazeutisch aktiven verbindung (granisetron) ATE299144T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200713A ES2197001B1 (es) 2002-03-26 2002-03-26 Procedimiento de obtencion de un compuesto farmaceuticamente activo.
PCT/IB2003/001058 WO2003080606A1 (en) 2002-03-26 2003-03-21 Process for preparing a pharmaceutically active compound (granisetron)

Publications (1)

Publication Number Publication Date
ATE299144T1 true ATE299144T1 (de) 2005-07-15

Family

ID=28051970

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706845T ATE299144T1 (de) 2002-03-26 2003-03-21 Verfahren zur herstellung einer pharmazeutisch aktiven verbindung (granisetron)

Country Status (14)

Country Link
US (1) US7071209B2 (de)
EP (1) EP1487833B1 (de)
JP (1) JP4560293B2 (de)
KR (1) KR100835553B1 (de)
AT (1) ATE299144T1 (de)
AU (1) AU2003208552A1 (de)
CA (1) CA2481703A1 (de)
DE (1) DE60300986D1 (de)
ES (1) ES2197001B1 (de)
IL (1) IL164742A0 (de)
PL (1) PL211464B1 (de)
PT (1) PT1487833E (de)
TW (1) TWI291959B (de)
WO (1) WO2003080606A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210065B1 (pl) 2002-09-25 2011-11-30 Memory Pharm Corp Związki indazole, benzotiazole i benzoizotiazole, kompozycje farmaceutyczne je zawierające oraz zastosowanie związków
BRPI0417323A (pt) 2003-12-22 2007-03-27 Memory Pharm Corp indóis, 1h-indazóis, 1,2-benzisoxazóis, e 1,2-benzisotiazóis, composto, composição farmacêutica e usos dos mesmos
CA2560741C (en) 2004-03-25 2013-08-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
JP2007534692A (ja) 2004-04-22 2007-11-29 メモリー・ファーマシューティカルズ・コーポレイション インドール、1h−インダゾール、1,2−ベンズイソキサゾール、1,2−ベンゾイソチアゾール、ならびにその調製および使用
DE602005027452D1 (de) 2004-05-07 2011-05-26 Memory Pharm Corp 1h-indazole, benzothiazole, 1,2-benzisoxazole, 1,2-benzisothiazole und chromone und deren herstellung und verwendungen
AU2005319248A1 (en) 2004-12-22 2006-06-29 Memory Pharmaceuticals Corporation Nicotinic alpha-7 receptor ligands and preparation and uses thereof
RU2420525C2 (ru) * 2005-07-11 2011-06-10 Мицубиси Танабе Фарма Корпорейшн Производные оксимов и их получение
US8911751B2 (en) 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
WO2007088557A1 (en) * 2006-02-01 2007-08-09 Natco Pharma Limited Process for highly pure crystalline granisetron base
US20080242696A1 (en) * 2007-03-27 2008-10-02 Chemagis Ltd. Crystalline granisetron base and production process therefor
US8304426B2 (en) 2007-06-13 2012-11-06 Inke, S.A. Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it
CA2734900A1 (en) * 2008-08-19 2010-02-25 Shu-Ping Chen Polymorphic form of granisetron hydrochloride and methods of making the same
US20120101089A1 (en) * 2010-10-26 2012-04-26 Ashwani Agarwal Anti-Emetic Substance
CN112778203B (zh) * 2021-01-29 2022-02-15 兰州交通大学 1h-吲唑-3-羧酸衍生物及格拉斯琼和氯尼达明的制备方法
CN115372487B (zh) * 2021-05-18 2023-10-10 成都倍特得诺药业有限公司 盐酸格拉司琼中杂质e的hplc测定方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (de) 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
GB9404055D0 (en) * 1994-03-03 1994-04-20 Smithkline Beecham Plc Novel process
GB9602862D0 (en) * 1996-02-13 1996-04-10 Smithkline Beecham Plc Novel process
GB9602866D0 (en) * 1996-02-13 1996-04-10 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
ES2197001A1 (es) 2003-12-16
JP2006511439A (ja) 2006-04-06
IL164742A0 (en) 2005-12-18
CA2481703A1 (en) 2003-10-02
KR20040099361A (ko) 2004-11-26
EP1487833A1 (de) 2004-12-22
US7071209B2 (en) 2006-07-04
PL374447A1 (en) 2005-10-17
TW200305572A (en) 2003-11-01
AU2003208552A1 (en) 2003-10-08
WO2003080606A1 (en) 2003-10-02
TWI291959B (en) 2008-01-01
US20050124650A1 (en) 2005-06-09
WO2003080606A8 (en) 2005-03-17
ES2197001B1 (es) 2004-11-16
JP4560293B2 (ja) 2010-10-13
KR100835553B1 (ko) 2008-06-09
EP1487833B1 (de) 2005-07-06
DE60300986D1 (de) 2005-08-11
PL211464B1 (pl) 2012-05-31
PT1487833E (pt) 2005-11-30

Similar Documents

Publication Publication Date Title
ATE299144T1 (de) Verfahren zur herstellung einer pharmazeutisch aktiven verbindung (granisetron)
JP2010532340A5 (de)
NZ553127A (en) L-lactic, saccharin, cinnamic, salicyclic, benzenesulphonic and naphthalene-1,5-disulphonic acid addition salts of lercanidipine
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
ATE549321T1 (de) Verfahren zur herstellung von phenylalaninderivaten mit chinazolindiongerüsten, und zwischenprodukte für die herstellung
IS5883A (is) Aðferð til framleiðslu á hreinu sítalóprami
DE60326341D1 (de) Verfahren zur herstellung von anthranilsäurederivat-hydrat
ATE544744T1 (de) Verfahren zur herstellung von benzoesaure derivaten
IL166985A (en) Method for the purification of lansoprazole
JP2016531925A (ja) ペメトレキセド製造のための中間体製造方法及びこれを用いて高純度ペメトレキセドを製造する方法
US20160355533A1 (en) Crystalline Fosaprepitant Dicyclohexylamine Salt And Its Preparation
ES2348197T3 (es) Procedimiento para la preparacion de abacavir.
CA2404736A1 (en) Process for producing amine derivatives
ITMI950389A1 (it) Procedimento per la metilazione del 2,2,6,6-tetrametil-4-piperidone (triacetonammina)
EP1787983A4 (de) Verfahren zur herstellung von isoindolderivaten
ITMI990802A1 (it) Processo per la preparazione del pirlindolo cloridrato
UA89037C2 (ru) Способ получения кислотно-аддитивной соли венлафаксина
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
GEP20074025B (en) Process for preparing acid salts of gemifloxacin
KR20160061542A (ko) 새로운 루리코나졸 이성체 분리 방법
DE602006015241D1 (de) Verbessertes verfahren zur herstellung von rivastigmin
US20030191310A1 (en) Method for producing lamotrigine from alpha-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction
US20070054960A1 (en) Sertraline acid addition salt, its preparation and its use in the preparation of sertraline hydrochloride form II
ATE414071T1 (de) Verbessertes verfahren zur herstellung von 4- hydroxypyran-2-onderivaten
KR20160065496A (ko) 페녹시피리미디논 유사체의 재결정을 통한 정제 방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties